Hypoaldosteronism natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
If left untreated, hypoaldosteronism can progress to hyperkalemia, hyponatremia, metabolic acidosis with hypo or hyper-volemia. Common complications of hypoaldosteronism include hyperkalemia, metabolic acidosis, hypotension, hypovolemia and hyponatremia.




Common complications of hypoaldosteronism include hyperkalemia, metabolic acidosis, hypotension, hypovolemia and hyponatremia.
Prognosis is generally egood/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==

Revision as of 14:29, 31 August 2017

Hypoaldosteronism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoaldosteronism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoaldosteronism natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoaldosteronism natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoaldosteronism natural history, complications and prognosis

CDC on Hypoaldosteronism natural history, complications and prognosis

Hypoaldosteronism natural history, complications and prognosis in the news

Blogs on Hypoaldosteronism natural history, complications and prognosis

Directions to Hospitals Treating Hypoaldosteronism

Risk calculators and risk factors for Hypoaldosteronism natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

If left untreated, hypoaldosteronism can progress to hyperkalemia, hyponatremia, metabolic acidosis with hypo or hyper-volemia. Common complications of hypoaldosteronism include hyperkalemia, metabolic acidosis, hypotension, hypovolemia and hyponatremia.


Natural History, Complications, and Prognosis

Natural History

If left untreated, hypoaldosteronism can progress to hyperkalemia and hyponatremia with hypo or hyper volemia. Hyperkalemia is an acute life threatening condition since it can alter the electrical activity of the heart and lead to life threatening rhythms. Patients with severe hyperkalemia (>7.5 mmol/l) may present with bundle branch blocks or fascicular blocks. When serum potassium level ≥ 9 mEq/L, hyperkalemia may lead to ventricular fibrillation, PEA and even cardiac arrest. Hyponatremia is unusual in isolated hypoaldosteronism since under normal conditions cortisol leads to suppression of ADH. However, patients of adrenal insufficiency have decreased cortisol and aldosterone which may progress to hyponatremia. Depending upon the presence of underlying conditions such as kidney disease or heart condition patient may be hypervolemic. Otherwise, aldosterone deficiency leads to decreased sodium and water absorption which predisposes to hypovolemia.

Complications

  • Common complications of hypoaldosteronism include:
    • Hyperkalemia
    • Hypotension
    • Hypovolemia
    • Metabolic acidosis
    • Hyponatremia

Prognosis

  • Depending on the extent of the hyperkalemia and underlying renal or adrenal condition at the time of diagnosis, the prognosis of hypoaldosteronism may vary.
  • Prognosis is generally good for patients of hypoaldosteronism who receive treatment.
  • Untreated patients risk having hyperkalemia which is associated with cardiac arrhythmias that can be fatal.
  • Patient having underlying renal insufficiency or diabetic nephropathy generally progresses to end stage stage renal disease. Drugs such as ACEi and ARBs which are the mainstay of treatment with diabetes and renal dysfunction are avoided in hypoaldosteronism since these may lead to hyperkalemia.

References

Template:WH Template:WS